Home » Archive by Category


The Salk Institute for Biological Studies – GLASSWASHER (E961) (La Jolla)

November 25, 2015 – 1:25 pm

The Salk Institute for Biological Studies is one of the world’s preeminent basic research institutions, where internationally renowned faculty probe fundamental life science questions in a unique, collaborative, and creative environment. Focused on b […

Sr. Equipment & Facilities Assistant – Ajinomoto Althea, Inc. – San Diego, CA

November 25, 2015 – 1:01 pm

Is a fully integrated contract development and manufacturing organization providing clinical drug process development and manufacturing services to global…
From Ajinomoto Althea, Inc. – 25 Nov 2015 20:01:42 GMT
– View all San…

Neurocrine Biosciences to Present at the 27th Annual Piper Jaffray Healthcare Conference

November 25, 2015 – 11:00 am

Live Audio Webcast will be on December 2, 2015

SAN DIEGO, Nov. 25, 2015 /PRNewswire/ — Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and CEO of Neurocrine Biosciences, will be presenting at the 27th Annual Piper Jaffray Healthcare Conference in New York.

The live presentation takes place on Wednesday, December 2 at 11:00am ET (8:00am PT).  The presentation will be webcast and may be accessed on the Company’s website at http://www.neurocrine.com.  

Listeners are encouraged to visit the website approximately 5 minutes prior to the presentation to download or install any necessary software.  A replay of the presentation will be available on the website approximately one hour after the conclusion of the event and will be archived for one month.

About Neurocrine Biosciences

Neurocrine Biosciences, Inc. discovers and develops innovative and life-changing pharmaceuticals, in diseases with high unmet medical needs, through its novel R&D platform, focused on neurological and endocrine based diseases and disorders.  The Company’s two lead late-stage clinical programs are elagolix, a gonadotropin-releasing hormone antagonist for women’s health that is partnered with AbbVie Inc., and NBI-98854, a vesicular monoamine transporter 2 inhibitor for the treatment of movement disorders.  Neurocrine intends to maintain certain commercial rights to its VMAT2 inhibitor for evolution into a fully-integrated pharmaceutical company. 

Neurocrine Biosciences, Inc. news releases are available through the Company’s website via the internet at http://www.neurocrine.com.


SOURCE Neurocrine Biosciences, Inc.

New Bio Fund Partner Describes A16Z Investment Strategy

November 25, 2015 – 8:08 am

When Marc Andreessen and Ben Horowitz founded their namesake venture firm in 2009, they laid out a clear-but-narrow vision for investing in a new wave of Web-based innovation. Andreessen, in…

[[Click headline to continue reading.]]

Orexigen Therapeutics to Speak at the Piper Jaffray 27th Annual Healthcare Conference

November 25, 2015 – 7:00 am

SAN DIEGO, Nov. 25, 2015 /PRNewswire/ — Orexigen® Therapeutics, Inc. (Nasdaq: OREX) today announced that management will participate in a fireside chat discussion at the Piper Jaffray 27th Annual Healthcare Conference in New York. The discussion is scheduled for Wednesday, December 2, at 8:00 a.m. Eastern Time.

To listen to the live webcast or a replay of the discussion, please visit the Investors section of the Company’s website at www.orexigen.com.  A replay will be available for 14 days after the event. 

Orexigen Contact: 

Media Contact:

McDavid Stilwell 

Julie Normart

VP, Corporate Communications and Business Development


(858) 875-8629

(415) 946-1087




SOURCE Orexigen Therapeutics, Inc.

Usability Engineer – International Programming & Systems Inc. – San Diego, CA

November 25, 2015 – 4:52 am

Their customers include genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations and biotechnology companies….$35 an hour
From International Programming & Systems Inc. – 25 Nov 2015 11…

Executive Director, Product Development – BioMarin Pharmaceutical Inc. – San Diego, CA

November 25, 2015 – 3:28 am

A solid business background and 10+ years in the biotechnology/ pharmaceutical industry, some of which leading cross-functional teams, is highly preferred….
From BioMarin Pharmaceutical Inc. – 25 Nov 2015 10:28:30 GMT
– View …

Software Quality Engineer – BioNano Genomics – San Diego, CA

November 25, 2015 – 12:19 am

He or she should feel comfortable operating on multiple platforms, writing scripts to automate testing, carrying out complex analysis, and ideally have…
From BioNano Genomics – 25 Nov 2015 07:19:50 GMT
– View all San Diego jobs

Lab Technician – Synectics – San Diego, CA

November 24, 2015 – 11:19 pm

SPECIFIC DUTIES Primary responder to customer requests to install, configure, maintain, repair, calibrate and complete preventive maintenance on multi-vendor
From JobServe USA – 25 Nov 2015 06:19:47 GMT
– View all San Diego jobs

At Duchenne Panel, Parents Plead With Experts, FDA Decision Looms

November 24, 2015 – 8:20 pm

In one of the more dramatic biotech events in recent memory, the FDA convened an advisory panel on Tuesday to weigh the risks and benefits of a drug called drisapersen, which has the chance to be the…

[[Click headline to continue reading.]]